Skip to main content
Top
Published in: International Journal of Colorectal Disease 4/2017

01-04-2017 | Original Article

Post-operative recurrence of Crohn’s disease after definitive stoma: an underestimated risk

Authors: Dine Koriche, Corinne Gower-Rousseau, Charbel Chater, Alain Duhamel, Julia Salleron, Noémie Tavernier, Jean-Frédéric Colombel, Benjamin Pariente, Antoine Cortot, Philippe Zerbib

Published in: International Journal of Colorectal Disease | Issue 4/2017

Login to get access

Abstract

Introduction

Crohn’s disease (CD) is a progressive inflammatory disease affecting the entire gastrointestinal tract. The need for a definitive stoma (DS) is considered as the ultimate phase of damage. It is often believed that the risk of further disease progression is small when a DS has been performed.

Aims

The goals of the study were to establish the rate of CD recurrence above the DS and to identify predictive factors of CD recurrence at the time of DS.

Methods

We retrospectively reviewed all medical records of consecutive CD patients having undergone DS between 1973 and 2010. We collected clinical data at diagnosis, CD phenotype, treatment, and surgery after DS and mortality. Stoma was considered as definitive when restoration of continuity was not possible due to proctectomy, rectitis, anoperineal lesions (APL), or fecal incontinence. Clinical recurrence (CR) was defined as the need for re-introduction or intensification of medical therapy, and surgical recurrence (SR) was defined as a need for a new intestinal resection.

Results

Eighty-three patients (20 males, 63 females) with a median age of 34 years at CD diagnosis were included. The median time between diagnosis and DS was 9 years. The median follow-up after DS was 10 years. Thirty-five patients (42%) presented a CR after a median time of 28 months (2–211) and 32 patients (38%) presented a SR after a median time of 29 months (4–212). In a multivariate analysis, APL (HR = 5.1 (1.2–21.1), p = 0.03) and colostomy at time of DS (HR = 3.8 (1.9–7.3), p = 0.0001) were associated factors with the CR.

Conclusion

After DS for CD, the risk of clinical recurrence was high and synonymous with surgical recurrence, especially for patients with APL and colostomy.
Literature
1.
go back to reference Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001 Dec) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782CrossRefPubMedPubMedCentral Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001 Dec) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782CrossRefPubMedPubMedCentral
2.
go back to reference Cosnes J1, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250CrossRefPubMed Cosnes J1, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250CrossRefPubMed
3.
go back to reference Etienney I, Bouhnik Y, Gendre JP et al (2004) Crohn’s disease over 20 years after diagnosis in a referral population. Gastroenterol Clin Biol 28(12):1233–1239CrossRefPubMed Etienney I, Bouhnik Y, Gendre JP et al (2004) Crohn’s disease over 20 years after diagnosis in a referral population. Gastroenterol Clin Biol 28(12):1233–1239CrossRefPubMed
4.
go back to reference Bouguen G, Chevaux JB, Peyrin-Biroulet L (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol 17(5):547–556CrossRefPubMedPubMedCentral Bouguen G, Chevaux JB, Peyrin-Biroulet L (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol 17(5):547–556CrossRefPubMedPubMedCentral
5.
go back to reference Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J et al (2014) Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 63(10):1607–1616CrossRefPubMed Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J et al (2014) Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 63(10):1607–1616CrossRefPubMed
6.
go back to reference Post S, Herfarth C, Schumacher H, Golling M, Schurmann G, Timmermanns G (1995) Experience with ileostomy and colostomy in Crohn’s disease. Br J Surg 82(12):1629–1633CrossRefPubMed Post S, Herfarth C, Schumacher H, Golling M, Schurmann G, Timmermanns G (1995) Experience with ileostomy and colostomy in Crohn’s disease. Br J Surg 82(12):1629–1633CrossRefPubMed
7.
go back to reference Coscia M, Gentilini L, Laureti S, Gionchetti P, Rizzello F, Campieri M et al (2013) Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Color Dis 15(9):1115–1122 Coscia M, Gentilini L, Laureti S, Gionchetti P, Rizzello F, Campieri M et al (2013) Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Color Dis 15(9):1115–1122
8.
go back to reference Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME (2007) Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon rectum 50(12):2067–2074 15 Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME (2007) Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon rectum 50(12):2067–2074 15
9.
go back to reference Gooszen AW, Geelkerken RH, Hermans J, Lagaay MB, Gooszen HG (2000) Quality of life with a temporary stoma: ileostomy vs. colostomy. Dis Colon rectum 43(5):650–655 Gooszen AW, Geelkerken RH, Hermans J, Lagaay MB, Gooszen HG (2000) Quality of life with a temporary stoma: ileostomy vs. colostomy. Dis Colon rectum 43(5):650–655
10.
go back to reference Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD (1999) Quality of life in stoma patients. Dis Colon rectum 42(12):1569–1574 Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD (1999) Quality of life in stoma patients. Dis Colon rectum 42(12):1569–1574
11.
go back to reference Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG (2000) Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg 87(8):1063–1066CrossRefPubMed Edwards CM, George BD, Jewell DP, Warren BF, Mortensen NJ, Kettlewell MG (2000) Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg 87(8):1063–1066CrossRefPubMed
12.
go back to reference Glotzer DJ, Stone PA, Patterson JF (1967) Prognosis after surgical treatment of granulomatous colitis. N Engl J Med 277(6):273–279CrossRefPubMed Glotzer DJ, Stone PA, Patterson JF (1967) Prognosis after surgical treatment of granulomatous colitis. N Engl J Med 277(6):273–279CrossRefPubMed
13.
go back to reference Korelitz BI, Present DH, Alpert LI, Marshak RH, Janowitz HD (1972) Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med 287(3):110–115CrossRefPubMed Korelitz BI, Present DH, Alpert LI, Marshak RH, Janowitz HD (1972) Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med 287(3):110–115CrossRefPubMed
14.
15.
go back to reference Vender RJ, Rickert RR, Spiro HM (1979) The outlook after total colectomy in patients with Crohn’s colitis and ulcerative colitis. J Clin Gastroenterol 1(3):209–217CrossRefPubMed Vender RJ, Rickert RR, Spiro HM (1979) The outlook after total colectomy in patients with Crohn’s colitis and ulcerative colitis. J Clin Gastroenterol 1(3):209–217CrossRefPubMed
16.
go back to reference Goligher JC (1985) The long-term results of excisional surgery for primary and recurrent Crohn’s disease of the large intestine. Dis Colon rectum 28(1):51–55 Goligher JC (1985) The long-term results of excisional surgery for primary and recurrent Crohn’s disease of the large intestine. Dis Colon rectum 28(1):51–55
17.
go back to reference Scammell BE, Andrews H, Allan RN, Alexander-Williams J, Keighley MR (1987) Results of proctocolectomy for Crohn’s disease. Br J Surg 74(8):671–674CrossRefPubMed Scammell BE, Andrews H, Allan RN, Alexander-Williams J, Keighley MR (1987) Results of proctocolectomy for Crohn’s disease. Br J Surg 74(8):671–674CrossRefPubMed
18.
go back to reference Yamamoto T, Allan RN, Keighley MR (2000) Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon rectum 43(2):249–256 16 Yamamoto T, Allan RN, Keighley MR (2000) Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon rectum 43(2):249–256 16
19.
go back to reference Bernell O, Lapidus A, Hellers G (2001) Recurrence after colectomy in Crohn’s colitis. Dis Colon rectum 44(5):647–654 Bernell O, Lapidus A, Hellers G (2001) Recurrence after colectomy in Crohn’s colitis. Dis Colon rectum 44(5):647–654
20.
go back to reference Amiot A, Gornet JM, Baudry C, Munoz-Bongrand N, Auger M, Simon M et al (2011) Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 43(9):698–702CrossRefPubMed Amiot A, Gornet JM, Baudry C, Munoz-Bongrand N, Auger M, Simon M et al (2011) Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 43(9):698–702CrossRefPubMed
21.
go back to reference Steinberg DM, Allan RN, Thompson H, Brooke BN, Alexander-Williams J, Cooke WT (1974) Excisional surgery with ileostomy for Crohn’s colitis with particular reference to factors affecting recurrence. Gut 15(11):845–851CrossRefPubMedPubMedCentral Steinberg DM, Allan RN, Thompson H, Brooke BN, Alexander-Williams J, Cooke WT (1974) Excisional surgery with ileostomy for Crohn’s colitis with particular reference to factors affecting recurrence. Gut 15(11):845–851CrossRefPubMedPubMedCentral
22.
go back to reference Ho I, Greenstein AJ, Bodian CA, Janowitz HD (1995) Recurrence of Crohn’s disease in end ileostomies. Inflamm Bowel Dis 1(3):173–178PubMed Ho I, Greenstein AJ, Bodian CA, Janowitz HD (1995) Recurrence of Crohn’s disease in end ileostomies. Inflamm Bowel Dis 1(3):173–178PubMed
23.
go back to reference Ecker KW, Gierend M, Kreissler-Haag D, Feifel G (2001) Reoperations at the ileostomy in Crohn’s disease reflect inflammatory activity rather than surgical stoma complications alone. Int J Color Dis 16(2):76–80CrossRef Ecker KW, Gierend M, Kreissler-Haag D, Feifel G (2001) Reoperations at the ileostomy in Crohn’s disease reflect inflammatory activity rather than surgical stoma complications alone. Int J Color Dis 16(2):76–80CrossRef
24.
go back to reference Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F (2005) Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon rectum 48(5):963–969 Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F (2005) Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon rectum 48(5):963–969
25.
go back to reference Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753CrossRefPubMedPubMedCentral Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753CrossRefPubMedPubMedCentral
26.
go back to reference Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J (2006) Predictors of Crohn’s disease. Gastroenterology 130(3):650–656CrossRefPubMed Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J (2006) Predictors of Crohn’s disease. Gastroenterology 130(3):650–656CrossRefPubMed
27.
28.
go back to reference Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M et al (2009) Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136(2):441–450CrossRefPubMed Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M et al (2009) Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136(2):441–450CrossRefPubMed
29.
go back to reference Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D (2010) Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol 8(7):591–599CrossRefPubMed Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D (2010) Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol 8(7):591–599CrossRefPubMed
30.
go back to reference Sorrentino D (2013) State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 10(7):413–422CrossRefPubMed Sorrentino D (2013) State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 10(7):413–422CrossRefPubMed
Metadata
Title
Post-operative recurrence of Crohn’s disease after definitive stoma: an underestimated risk
Authors
Dine Koriche
Corinne Gower-Rousseau
Charbel Chater
Alain Duhamel
Julia Salleron
Noémie Tavernier
Jean-Frédéric Colombel
Benjamin Pariente
Antoine Cortot
Philippe Zerbib
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 4/2017
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-016-2707-2

Other articles of this Issue 4/2017

International Journal of Colorectal Disease 4/2017 Go to the issue